Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Triochem Products's share price for the quarter that ended in Mar. 2026 was ₹17.4. Triochem Products's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 0.25 Mil. Therefore, Triochem Products's market cap for the quarter that ended in Mar. 2026 was ₹4.26 Mil.
Triochem Products's quarterly market cap
stayed the same
from Sep. 2025 (₹4.26 Mil) to Dec. 2025 (₹4.26 Mil) and
stayed the same
from Dec. 2025 (₹4.26 Mil) to Mar. 2026 (₹4.26 Mil).
Triochem Products's annual market cap
stayed the same
from Mar. 2024 (₹4.26 Mil) to Mar. 2025 (₹4.26 Mil) and
stayed the same
from Mar. 2025 (₹4.26 Mil) to Mar. 2026 (₹4.26 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Triochem Products's Enterprise Value for Today is ₹-113.08 Mil.
Triochem Products (BOM:512101) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Triochem Products Market Cap Related Terms
Triochem Products Market Cap Historical Data
* Premium members only.
The historical data trend for Triochem Products's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:512101 vs GOVX, MBVXQ, HSTC: Market Cap Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Triochem Products's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Triochem Products Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Triochem Products's Market Cap distribution charts can be found below:
* The bar in red indicates where Triochem Products's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Triochem Products's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Triochem Products (BOM:512101) has a Market Cap of ₹4.26 Mil as of Jul. 12, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Triochem Products and its competitors.
Is Triochem Products' Market Cap too high?
Triochem Products' current Market Cap is ₹4.26 Mil.
How does Triochem Products' Market Cap compare to GOVX and MBVXQ?
Triochem Products' Market Cap of ₹4.26 Mil can be compared against companies in the Drug Manufacturers industry. The industry median Market Cap is 213.52. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 213.52, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Triochem Products and its competitors. For the Drug Manufacturers industry, the median Market Cap is 213.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Triochem Products's current Market Cap is ₹4.26 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Triochem Products stock overvalued right now?
Triochem Products (BOM:512101) has a current Market Cap of ₹4.26 Mil. The stock's GF Value™ is ₹10.79, compared to a current price of ₹17.40 — trading 61.3% above its estimated fair value. The current Market Cap is ₹4.26 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Triochem Products (BOM:512101), the current Market Cap is ₹4.26 Mil as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Triochem Products Ltd is an India-based pharmaceutical company. It is engaged in manufacturing and exporting of pharmaceutical bulk drugs, active pharmaceutical ingredients, and chemicals. The company's product range includes iodine compounds, citrates, and piperazine salts. Its key markets are Europe, America, and South-East Asia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:512101 has been successfully added to your 